[Clinical significance of ERCC1, RRM1 and TS in non-small cell lung cancer]

Zhongguo Fei Ai Za Zhi. 2014 Jun 20;17(6):496-500. doi: 10.3779/j.issn.1009-3419.2014.06.11.
[Article in Chinese]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Carcinoma, Non-Small-Cell Lung / genetics
  • Carcinoma, Non-Small-Cell Lung / metabolism*
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Endonucleases / genetics
  • Endonucleases / metabolism*
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / genetics
  • Lung Neoplasms / metabolism*
  • Nucleoside-Phosphate Kinase / genetics
  • Nucleoside-Phosphate Kinase / metabolism*
  • Ribonucleoside Diphosphate Reductase
  • Tumor Suppressor Proteins / genetics
  • Tumor Suppressor Proteins / metabolism*

Substances

  • Antineoplastic Agents
  • DNA-Binding Proteins
  • Tumor Suppressor Proteins
  • RRM1 protein, human
  • Ribonucleoside Diphosphate Reductase
  • Nucleoside-Phosphate Kinase
  • dTMP kinase
  • ERCC1 protein, human
  • Endonucleases

Grants and funding

本课题受北京市卫生系统高层次卫生技术人才培养计划（No.2009-2-17）、国家973计划（No.2011CB504300）、教育部高等学校博士学科专项科研基金（No.20130001110108）、教育部“创新团队发展计划”专项基金（No.IRT130031）资助